(Q37457142)

20 August 2017

Month-6 primary outcomes of the READ-3 study (Ranibizumab for Edema of the mAcula in Diabetes-Protocol 3 with high dose). (English)

1 reference

20 August 2017

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26228291%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

author name string

D V Do

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26228291%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

Y J Sepah

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26228291%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

D Boyer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26228291%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

D Callanan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26228291%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

R Gallemore

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26228291%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

M Bennett

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26228291%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

D M Marcus

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26228291%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

M A Sadiq

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26228291%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

N Rajagopalan

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26228291%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

P A Campochiaro

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26228291%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

Q D Nguyen

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26228291%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

READ-3 Study Group

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26228291%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

publication date

31 July 2015

1 reference

20 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26228291%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26228291%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26228291%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

page(s)

1538-1544

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26228291%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/eye.2015.142

15 June 2020

exact match

0 references

cites work

Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5129796

The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5129796

Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5129796

Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5129796

Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in diabetes (READ-2) study

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5129796

Ranibizumab for edema of the macula in diabetes study: 3-year outcomes and the need for prolonged frequent treatment

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5129796

Vascular endothelial growth factor is a critical stimulus for diabetic macular edema

23 August 2017

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26228291

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/EYE.2015.142

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26228291%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

15 June 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26228291%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

PubMed publication ID

26228291

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26228291%20AND%20SRC:MED&resulttype=core&format=json